Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study
Identifieur interne : 002055 ( Main/Exploration ); précédent : 002054; suivant : 002056Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study
Auteurs : Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Robert Perneczky [Allemagne] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Giovanni Defazio [Italie] ; Giuseppe Rubini [Italie] ; Paolo Livrea [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-10-30.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- 123I‐FP‐CIT SPECT, Aged, Caudate Nucleus (metabolism), Caudate Nucleus (radionuclide imaging), Delusion, Delusions (psychology), Delusions (radionuclide imaging), Dopamine, Dopamine (metabolism), Dopamine Plasma Membrane Transport Proteins (metabolism), Female, Hallucination, Hallucinations (psychology), Hallucinations (radionuclide imaging), Humans, Image Processing, Computer-Assisted, Lewy Body Disease (metabolism), Lewy Body Disease (psychology), Lewy Body Disease (radionuclide imaging), Lewy body dementia, Male, Middle Aged, Neostriatum (metabolism), Neostriatum (radionuclide imaging), Nervous system diseases, Neuropsychological Tests, Nucleus Accumbens (metabolism), Nucleus Accumbens (radionuclide imaging), Parkinson Disease (psychology), Parkinson Disease (radionuclide imaging), Parkinsonism, Photon, Psychiatric Status Rating Scales, Putamen (metabolism), Putamen (radionuclide imaging), Radiopharmaceuticals (diagnostic use), Single photon emission tomography, Tomography, Emission-Computed, Single-Photon, Tropanes (diagnostic use), delusion, dementia with Lewy bodies, hallucination, parkinsonism.
- MESH :
- chemical , diagnostic use : Radiopharmaceuticals, Tropanes.
- chemical , metabolism : Dopamine, Dopamine Plasma Membrane Transport Proteins.
- metabolism : Caudate Nucleus, Lewy Body Disease, Neostriatum, Nucleus Accumbens, Putamen.
- psychology : Delusions, Hallucinations, Lewy Body Disease, Parkinson Disease.
- radionuclide imaging : Caudate Nucleus, Delusions, Hallucinations, Lewy Body Disease, Neostriatum, Nucleus Accumbens, Parkinson Disease, Putamen.
- Aged, Female, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Tomography, Emission-Computed, Single-Photon.
Abstract
Neuropsychiatric symptoms are frequent in dementia with Lewy bodies (DLB). Dopamine transporter (DAT) imaging with 123I‐labeled ligand N‐δ‐(fluoropropyl)‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)tropene (123I‐FP‐CIT), which reliably measures midbrain dopaminergic dysfunction, has provided important evidence on the neurobiological substrate of some of these symptoms including apathy and depression. However, little is known on DAT levels and other distressing symptoms such as delusions and hallucinations. Therefore, 123I‐FP‐CIT imaging was performed in 18 well‐characterized patients with DLB, and striatal DAT levels were correlated with the frequency/severity ratings of several neuropsychiatric symptoms. A wide range of neuropsychiatric symptoms could be observed in the sample. Significant correlations were observed between decreased striatal DAT levels and visual hallucinations. Although there were no correlations between striatal DAT levels and other neuropsychiatric symptoms, when considering the putamen and the caudate nucleus separately, delusions, depression, and apathy were inversely correlated to decreased caudate DAT levels. Theseresults provide intriguing evidence on the involvement of the mesocortical dopaminergic pathways in neuropsychiatric symptoms in DLB. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22702
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001A63
- to stream Istex, to step Curation: 001A63
- to stream Istex, to step Checkpoint: 000C57
- to stream PubMed, to step Corpus: 001B83
- to stream PubMed, to step Curation: 001B83
- to stream PubMed, to step Checkpoint: 001B69
- to stream Ncbi, to step Merge: 002796
- to stream Ncbi, to step Curation: 002796
- to stream Ncbi, to step Checkpoint: 002796
- to stream Main, to step Merge: 002916
- to stream PascalFrancis, to step Corpus: 000D28
- to stream PascalFrancis, to step Curation: 001F91
- to stream PascalFrancis, to step Checkpoint: 000D03
- to stream Main, to step Merge: 002E00
- to stream Main, to step Curation: 002055
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study</title><author><name sortKey="Roselli, Francesco" sort="Roselli, Francesco" uniqKey="Roselli F" first="Francesco" last="Roselli">Francesco Roselli</name></author><author><name sortKey="Pisciotta, Nicola M" sort="Pisciotta, Nicola M" uniqKey="Pisciotta N" first="Nicola M." last="Pisciotta">Nicola M. Pisciotta</name></author><author><name sortKey="Perneczky, Robert" sort="Perneczky, Robert" uniqKey="Perneczky R" first="Robert" last="Perneczky">Robert Perneczky</name></author><author><name sortKey="Pennelli, Michele" sort="Pennelli, Michele" uniqKey="Pennelli M" first="Michele" last="Pennelli">Michele Pennelli</name></author><author><name sortKey="Aniello, Maria S" sort="Aniello, Maria S" uniqKey="Aniello M" first="Maria S." last="Aniello">Maria S. Aniello</name></author><author><name sortKey="De Caro, Maria F" sort="De Caro, Maria F" uniqKey="De Caro M" first="Maria F." last="De Caro">Maria F. De Caro</name></author><author><name sortKey="Ferrannini, Ermanno" sort="Ferrannini, Ermanno" uniqKey="Ferrannini E" first="Ermanno" last="Ferrannini">Ermanno Ferrannini</name></author><author><name sortKey="Tartaglione, Bruno" sort="Tartaglione, Bruno" uniqKey="Tartaglione B" first="Bruno" last="Tartaglione">Bruno Tartaglione</name></author><author><name sortKey="Defazio, Giovanni" sort="Defazio, Giovanni" uniqKey="Defazio G" first="Giovanni" last="Defazio">Giovanni Defazio</name></author><author><name sortKey="Rubini, Giuseppe" sort="Rubini, Giuseppe" uniqKey="Rubini G" first="Giuseppe" last="Rubini">Giuseppe Rubini</name></author><author><name sortKey="Livrea, Paolo" sort="Livrea, Paolo" uniqKey="Livrea P" first="Paolo" last="Livrea">Paolo Livrea</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F21EC08D5D81C80F16150E182B7256E76288E908</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22702</idno><idno type="url">https://api.istex.fr/document/F21EC08D5D81C80F16150E182B7256E76288E908/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001A63</idno><idno type="wicri:Area/Istex/Curation">001A63</idno><idno type="wicri:Area/Istex/Checkpoint">000C57</idno><idno type="wicri:doubleKey">0885-3185:2009:Roselli F:severity:of:neuropsychiatric</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19705471</idno><idno type="wicri:Area/PubMed/Corpus">001B83</idno><idno type="wicri:Area/PubMed/Curation">001B83</idno><idno type="wicri:Area/PubMed/Checkpoint">001B69</idno><idno type="wicri:Area/Ncbi/Merge">002796</idno><idno type="wicri:Area/Ncbi/Curation">002796</idno><idno type="wicri:Area/Ncbi/Checkpoint">002796</idno><idno type="wicri:Area/Main/Merge">002916</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:09-0482391</idno><idno type="wicri:Area/PascalFrancis/Corpus">000D28</idno><idno type="wicri:Area/PascalFrancis/Curation">001F91</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000D03</idno><idno type="wicri:doubleKey">0885-3185:2009:Roselli F:severity:of:neuropsychiatric</idno><idno type="wicri:Area/Main/Merge">002E00</idno><idno type="wicri:Area/Main/Curation">002055</idno><idno type="wicri:Area/Main/Exploration">002055</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study</title><author><name sortKey="Roselli, Francesco" sort="Roselli, Francesco" uniqKey="Roselli F" first="Francesco" last="Roselli">Francesco Roselli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Max Planck Institute of Psychiatry, München</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Pisciotta, Nicola M" sort="Pisciotta, Nicola M" uniqKey="Pisciotta N" first="Nicola M." last="Pisciotta">Nicola M. Pisciotta</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Nuclear Medicine, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Perneczky, Robert" sort="Perneczky, Robert" uniqKey="Perneczky R" first="Robert" last="Perneczky">Robert Perneczky</name><affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Psychiatry and Psychotherapy, Technische Universität München</wicri:regionArea><placeName><settlement type="city">Munich</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region></placeName><orgName type="university">Université technique de Munich</orgName></affiliation></author><author><name sortKey="Pennelli, Michele" sort="Pennelli, Michele" uniqKey="Pennelli M" first="Michele" last="Pennelli">Michele Pennelli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Aniello, Maria S" sort="Aniello, Maria S" uniqKey="Aniello M" first="Maria S." last="Aniello">Maria S. Aniello</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="De Caro, Maria F" sort="De Caro, Maria F" uniqKey="De Caro M" first="Maria F." last="De Caro">Maria F. De Caro</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Ferrannini, Ermanno" sort="Ferrannini, Ermanno" uniqKey="Ferrannini E" first="Ermanno" last="Ferrannini">Ermanno Ferrannini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurology, “Madonnina” Hospital, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Tartaglione, Bruno" sort="Tartaglione, Bruno" uniqKey="Tartaglione B" first="Bruno" last="Tartaglione">Bruno Tartaglione</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Defazio, Giovanni" sort="Defazio, Giovanni" uniqKey="Defazio G" first="Giovanni" last="Defazio">Giovanni Defazio</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Rubini, Giuseppe" sort="Rubini, Giuseppe" uniqKey="Rubini G" first="Giuseppe" last="Rubini">Giuseppe Rubini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Nuclear Medicine, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author><author><name sortKey="Livrea, Paolo" sort="Livrea, Paolo" uniqKey="Livrea P" first="Paolo" last="Livrea">Paolo Livrea</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neurological and Psychiatric Sciences, University of Bari, Bari</wicri:regionArea><wicri:noRegion>Bari</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-10-30">2009-10-30</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2097">2097</biblScope><biblScope unit="page" to="2103">2103</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">F21EC08D5D81C80F16150E182B7256E76288E908</idno><idno type="DOI">10.1002/mds.22702</idno><idno type="ArticleID">MDS22702</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>123I‐FP‐CIT SPECT</term><term>Aged</term><term>Caudate Nucleus (metabolism)</term><term>Caudate Nucleus (radionuclide imaging)</term><term>Delusion</term><term>Delusions (psychology)</term><term>Delusions (radionuclide imaging)</term><term>Dopamine</term><term>Dopamine (metabolism)</term><term>Dopamine Plasma Membrane Transport Proteins (metabolism)</term><term>Female</term><term>Hallucination</term><term>Hallucinations (psychology)</term><term>Hallucinations (radionuclide imaging)</term><term>Humans</term><term>Image Processing, Computer-Assisted</term><term>Lewy Body Disease (metabolism)</term><term>Lewy Body Disease (psychology)</term><term>Lewy Body Disease (radionuclide imaging)</term><term>Lewy body dementia</term><term>Male</term><term>Middle Aged</term><term>Neostriatum (metabolism)</term><term>Neostriatum (radionuclide imaging)</term><term>Nervous system diseases</term><term>Neuropsychological Tests</term><term>Nucleus Accumbens (metabolism)</term><term>Nucleus Accumbens (radionuclide imaging)</term><term>Parkinson Disease (psychology)</term><term>Parkinson Disease (radionuclide imaging)</term><term>Parkinsonism</term><term>Photon</term><term>Psychiatric Status Rating Scales</term><term>Putamen (metabolism)</term><term>Putamen (radionuclide imaging)</term><term>Radiopharmaceuticals (diagnostic use)</term><term>Single photon emission tomography</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Tropanes (diagnostic use)</term><term>delusion</term><term>dementia with Lewy bodies</term><term>hallucination</term><term>parkinsonism</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Radiopharmaceuticals</term><term>Tropanes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term><term>Dopamine Plasma Membrane Transport Proteins</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Caudate Nucleus</term><term>Lewy Body Disease</term><term>Neostriatum</term><term>Nucleus Accumbens</term><term>Putamen</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Delusions</term><term>Hallucinations</term><term>Lewy Body Disease</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Caudate Nucleus</term><term>Delusions</term><term>Hallucinations</term><term>Lewy Body Disease</term><term>Neostriatum</term><term>Nucleus Accumbens</term><term>Parkinson Disease</term><term>Putamen</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Image Processing, Computer-Assisted</term><term>Male</term><term>Middle Aged</term><term>Neuropsychological Tests</term><term>Psychiatric Status Rating Scales</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dopamine</term><term>Délire</term><term>Démence à corps de Lewy</term><term>Hallucination</term><term>Parkinsonisme</term><term>Pathologie du système nerveux</term><term>Photon</term><term>Tomoscintigraphie émission monophotonique</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Neuropsychiatric symptoms are frequent in dementia with Lewy bodies (DLB). Dopamine transporter (DAT) imaging with 123I‐labeled ligand N‐δ‐(fluoropropyl)‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)tropene (123I‐FP‐CIT), which reliably measures midbrain dopaminergic dysfunction, has provided important evidence on the neurobiological substrate of some of these symptoms including apathy and depression. However, little is known on DAT levels and other distressing symptoms such as delusions and hallucinations. Therefore, 123I‐FP‐CIT imaging was performed in 18 well‐characterized patients with DLB, and striatal DAT levels were correlated with the frequency/severity ratings of several neuropsychiatric symptoms. A wide range of neuropsychiatric symptoms could be observed in the sample. Significant correlations were observed between decreased striatal DAT levels and visual hallucinations. Although there were no correlations between striatal DAT levels and other neuropsychiatric symptoms, when considering the putamen and the caudate nucleus separately, delusions, depression, and apathy were inversely correlated to decreased caudate DAT levels. Theseresults provide intriguing evidence on the involvement of the mesocortical dopaminergic pathways in neuropsychiatric symptoms in DLB. © 2009 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Italie</li></country><region><li>Bavière</li><li>District de Haute-Bavière</li></region><settlement><li>Munich</li></settlement><orgName><li>Université technique de Munich</li></orgName></list><tree><country name="Italie"><noRegion><name sortKey="Roselli, Francesco" sort="Roselli, Francesco" uniqKey="Roselli F" first="Francesco" last="Roselli">Francesco Roselli</name></noRegion><name sortKey="Aniello, Maria S" sort="Aniello, Maria S" uniqKey="Aniello M" first="Maria S." last="Aniello">Maria S. Aniello</name><name sortKey="De Caro, Maria F" sort="De Caro, Maria F" uniqKey="De Caro M" first="Maria F." last="De Caro">Maria F. De Caro</name><name sortKey="Defazio, Giovanni" sort="Defazio, Giovanni" uniqKey="Defazio G" first="Giovanni" last="Defazio">Giovanni Defazio</name><name sortKey="Ferrannini, Ermanno" sort="Ferrannini, Ermanno" uniqKey="Ferrannini E" first="Ermanno" last="Ferrannini">Ermanno Ferrannini</name><name sortKey="Livrea, Paolo" sort="Livrea, Paolo" uniqKey="Livrea P" first="Paolo" last="Livrea">Paolo Livrea</name><name sortKey="Pennelli, Michele" sort="Pennelli, Michele" uniqKey="Pennelli M" first="Michele" last="Pennelli">Michele Pennelli</name><name sortKey="Pisciotta, Nicola M" sort="Pisciotta, Nicola M" uniqKey="Pisciotta N" first="Nicola M." last="Pisciotta">Nicola M. Pisciotta</name><name sortKey="Rubini, Giuseppe" sort="Rubini, Giuseppe" uniqKey="Rubini G" first="Giuseppe" last="Rubini">Giuseppe Rubini</name><name sortKey="Tartaglione, Bruno" sort="Tartaglione, Bruno" uniqKey="Tartaglione B" first="Bruno" last="Tartaglione">Bruno Tartaglione</name></country><country name="Allemagne"><region name="Bavière"><name sortKey="Roselli, Francesco" sort="Roselli, Francesco" uniqKey="Roselli F" first="Francesco" last="Roselli">Francesco Roselli</name></region><name sortKey="Perneczky, Robert" sort="Perneczky, Robert" uniqKey="Perneczky R" first="Robert" last="Perneczky">Robert Perneczky</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002055 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002055 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F21EC08D5D81C80F16150E182B7256E76288E908
|texte= Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study
}}
| This area was generated with Dilib version V0.6.23. |  |